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ABSTRACT
Objective:We undertook the present study to attempt to apply clinical indicators predictive ofcervical
infection in nongravid populations with either Neisseria gonorrhoeae or Chlamydia trachomatis to
our pregnant population and to determine the significance of the clinical diagnosis of "cervicitis."
Methods: A retrospective chart review of all pregnant women with a final diagnosis of cervicitis
who were seen in the Medical College ofVirginia obstetrical emergency room was performed during
the period of September 1991 to December 1992.
Results: Given the diagnosis of cervicitis in our emergency department, we found that the clinical
examination predicted cervical infection with N. gonorrhoeae or C. trachomatis in only 20% of the
pregnant women. Gravidas with chlamydial infections were younger (20.1 +- 3.7 years) compared
with gravidas not infected (23.2 +_ 5.4 years) (P < 0.0001). They were also more likely to have a
diagnosis oflower urinary-tract infection [relative risk (RR) 2.89, 95% confidence interval (CI) 1.42-
5.85].
Conclusions: The clinical indicators of cervical infection with C. trachomatis and N. gonorrhoeae
were unreliable. (C) 1996 Wiley-Liss, Inc.
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creening populations of nongravid women re-
veals that several variables are predictive of Chla-
mydia tracaomatis infections: age younger than 24
years, intercourse with a new partner in the preced-
ing 2 months, purulent or mucopurulent cervical
exudate, endocervical bleeding induced by swab-
bing, and lack ofcontraception or use of a nonbarrier
method. Several studies in developing countries
aimed at identifying those variables that would sup-
port the clinical diagnosis of chlamydial or gonococ-
cal infections in pregnant women have produced
mixed results, z’3
To date, there have been no published studies
in industrialized countries to examine the value of
clinical indicators in predicting cervical infections
in pregnant women. We undertook the present
study to attempt to apply clinical indicators pre-
dictive of cervical infections with either Neisseria
gonorrhoeae or C. tracaomatis in nongravid popula-
tions to our pregnant population and to determine
the significance of the clinical diagnosis of "cer-
vicitis."
SUBJECTS AND METHODS
A retrospective chart review was carried out of all
pregnant women seen in the Medical College of
Virginia obstetrical emergency room with a final
diagnosis of cervicitis during the period of Septem-
ber 1991 to December 1992. This time was chosen
as a convenience sample to include approximately
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250 women. Cervicitis was defined as the presence
of endocervical mucopus, leukorrhea (>10 WBCs/
hpf), or cervical friability (cervical bleeding induced
with a swab). Lower urinary-tract infection, as diag-
nosed by urinalysis, was defined as the presence of
leukocytes, bacteria, nitrites, or erythrocytes in the
absence of large numbers of epithelial cells on a
clean-catch or catheterized urine specimen. All
women were interviewed and examined by either
an obstetrical resident or an obstetrics and gynecol-
ogy nurse practitioner. The data collected on all
patients included age, race, estimated gestational
age, gravidity, parity, presenting complaints, and
history of sexually transmitted diseases (STDs) in-
cluding chlamydial and gonococcal infections. In
addition, information was obtained regarding the
presence of endocervical mucopus or cervical fria-
bility, direct smear of endocervical secretions for
WBCs, results of wet mount examination of pooled
vaginal fluid for the presence ofWBCs and Tricho-
monas vaginalis, and any other diagnoses assigned
at the time of discharge.
Each patient underwent a speculum examina-
tion with collection of endocervical specimens for
N. gonorrhoeae culture and for chlamydial antigen
detection (Chlamydiazyme, Abbott Laboratories,
Chicago, IL). Each endocervical culture for N.
gonorrhoeae was inoculated onto Martin Lewis
Transgrow medium (Becton Dickinson, Cockeys-
ville, MD) and then incubated at 35C in a 5%
carbon dioxide atmosphere. A positive culture was
presumptively identified by a Gram’s stain of the
colonies and a positive oxidase test. The endocervi-
cal specimens for C. trachomatis were collected using
the STD-EZE collection kit (Abbott Laboratories).
The presence of the chlamydia antigen was deter-
mined in the clinical microbiology laboratory using
the Chlamydiazyme enzyme-linked immunosor-
bent assay (ELISA) test following the manufactur-
er’s directions.
A statistical analysis was performed utilizing the
Student’s t-test for continuous variables. The cate-
gorical variables were analyzed utilizing the chi-
square or Fisher exact test when appropriate.
P < 0.05 (using a two-tailed statistical test) was con-
sidered significant.
RESULTS
Two hundred fifty-five pregnant women with a di-
agnosis of cervicitis were seen between September
1991 and December 1992. The results of gonorrhea
and chlamydia testing were available for 251. Three
of the samples obtained for chlamydia testing read
as "inconclusive" were not included, leaving 248
patients for analysis. Ten (4%) women tested posi-
tive for N. gonorrhoeae and 42 (17%) tested positive
for C. trachomatis. Of those infected with gonorrhea,
3 (30%) were coinfected with chlamydia. Because
the clinical diagnosis of cervicitis was so poorly pre-
dictive of the presence of either N. gonorrhoeae or
C. trachomatis, we then examined the individual
clinical findings to determine whether any one was
a better predictor of the presence of infection in
pregnant women. Of the patients with gonococcal
infections, 40% had cervical friability, 50% had en-
docervical mucopus, and 80% had leukorrhea. In
those with chlamydial infections, friability was
noted in 55%, endocervical mucopus in 55%, and
leukorrhea in 88%. Friability was present in 127
patients, of whom 4 (3%) tested positive for N.
gonorrhoeae and 23 (18%) tested positive for C. tra-
chomatis. Mucopus was present in 119 patients, of
whom 5 (4%) tested positive for N. gonorrhoeae and
23 (19%) tested positive for C. trachomatis. Leukor-
rhea was seen in 211 patients, of whom 8 (4%)
tested positive for N. gonorrhoeae and 37 (17%)
tested positive for C. trachomatis.
The mean age of patients having a positive Chla-
mydiazyme was significantly younger compared
with those having a negative test: 20.1 + 3.7 vs.
23.2 + 5.4 years (P < 0.0001) (Table 1). Thirty-six
women (86%)with C. trachomatis were younger than
24 years. There were no significant differences be-
tween groups in gestational age, gravidity, parity,
history of STDs, complaints of dysuria, abdomi-
nopelvic pain, vaginal bleeding, or vaginal discharge
(Tables 1, 2). There were also no statistical differ-
ences in the incidence ofcervical friability, endocer-
vical mucopus, or WBCs or T. vaginalis on wet
mount (Table 3). There was an association between
the presence of a positive Chlamydiazyme test and
a final discharge diagnosis of lower urinary-tract
infection [P 0.006; relative risk (RR) 2.89, 95%
confidence interval (CI) 1.42-5.85].
DISCUSSION
STDs are common complications ofpregnancy, par-
ticularly in indigent urban populations, with N. gon-
orrhoeae and C. trachomatis being among the most
common organisms encountered. C. trachomatis is
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TABLE I. Comparison of characteristics of pregnant women with cervicitis, with and without gonoccocal or
chlamydial infection
N. gonorrhoeae C. trachomatis
Positive Negative Positive Negative
Characteristic (N 10) (N 238) P (N 42) (N 206)
Age (years) 22.2 _
5.0 22.7 _+ 5.2 NS 20.1 +_ 3.7 23.2 +_ 5.4 <0.0001
EGA (weeks) 18.7 _+ 11.3 17.9 9.7 NS 17.6 9.8 18.0 _
9.8 NS
Gravidity 3.3 ___
1.8 3.2 2.0 NS 3.0 +__ 2.3 3.2 _
1.9 NS
Parity 1.6 1.4 1.4 1.5 NS 1.3 _+ 1.4 1.5 1.5 NS
Abortus 0.7 +_ I.I 0.8-+ I.I NS 0.7_ 1.4 0.8_ I.I NS
aEGA estimated gestational age; NS not significant.
TABLE 2. Comparison of symptoms of pregnant women with cervicitis, with and without gonoccocal or
chlamydial infection
N. gonorrhoeae C. trachomatis
Positive Negative Positive Negative
Symptom (N 10) (N 238) P (N 42) (N 206) P
Bleeding 2 (20%) 112 (47%) NS 17 (40%) 97 (47%) NS
Discharge 4 (40%) 77 (32%) NS 14 (33%) 67 (33%) NS
Dysuria 2 (20%) 17 (7%) NS 5 (12%) 14 (7%) NS
Pain 6 (60%) 137 (57%) NS 25 (59%) 118 (57%) NS
aNS not significant.
TABLE 3. Comparison of physical findings of pregnant women with cervicitis, with and without gonoccocal or
chlamydial infection
N. gonorrhoeae C. trachomatis
Positive Negative Positive Negative
Physical finding (N 10) (N 238) P (N 42) (N 206) P
Friability 4 (40%) 123 (52%) NS 23 (55%) 104 (50%) NS
Mucopus 5 (50%) 104 (44%) NS 23 (55%) 86 (42%) NS
Leukorrhea 8 (80%) 203 (85%) NS 37 (88%) 174 (84%) NS
Trichomonas (10%) 20 (8%) NS 3 (7%) 18 (9%) NS
aNS not significant.
the most common sexually transmitted bacterial mi-
croorganism, with a prevalence from 2 to 37% in
pregnant women. N. gonorrhoeae was found in ap-
proximately 4% of pregnant patients in a study at
Parkland Memorial Hospital in Dallas, TX; approxi-
mately 46% of gravid women with gonococcal infec-
tions were coinfected with C. trachomatis.
Braddick et al. examined pregnant women in
an antenatal clinic in Nairobi, Kenya, and found
that the prevalence of C. trachomatis and N. gonor-
rhoeae was 8% and 10%, respectively. The presence
of clinical cervicitis (defined as the presence of ei-
ther endocervical mucopus or induced cervical
bleeding) and having more than one sexual partner
during the pregnancy were independently pre-
dictive of a true cervical infection, with sensitivities
and specificities of61% and 79% and 68% and 93%,
respectively. The combination of more than one
sexual partner during the pregnancy and the clinical
diagnosis of cervicitis raised the specificity to 86%;
however, the sensitivity dropped to 11%.
Vuylsteke and colleagues studied 1,160 preg-
nant women presenting to an antenatal health clinic
for initial prenatal care in Kinasha, Zaire. Those
patients who were included in the study had symp-
toms of vaginal discharge or abdominal pain. Nearly
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2% of the women tested positive for N. gonorrhoeae
and 5.2% tested positive for C. trachomatis. The
factors significantly associated with cervical infec-
tions in pregnant women included younger age
(mean 22.3 years), single marital status, having had
more than one sexual partner in the preceding 12
months, a vaginal discharge, >10 WBCs/hpf in a
cervical or vaginal specimen, and a positive leuko-
cyte-esterase dipstick when testing a midstream
urine sample. However, no single symptom or phys-
ical sign reached an acceptable level of sensitivity
and specificity to be predictive of cervical infec-
tions. A scoring system based on marital status, ma-
ternal age, symptoms ofvaginal discharge or abdom-
inal pain, and leukocyte-esterase dipstick of urine
was formulated and used in a diagnostic model for
the prediction of cervical infections. In their popula-
tion, they were able to predict infections with a
sensitivity of 72% and specificity of 74%; however,
the positive predictive value reached only 16%.
Of the variables shown to be associated with
cervical C. trachomatis infections in nongravid
women, only the maternal age was significantly dif-
ferent in our study. We were unable to correlate
other clinical signs and symptoms shown to be asso-
ciated with a positive gonococcal or chlamydial test
in nongravid women. Our study revealed no signifi-
cant association between "clinical cervicitis" in
pregnancy and a true cervical infection.
There was a correlation between the diagnosis
of lower urinary-tract infection and a subsequent
positive test for C. trachomatis. Gravid women with
this diagnosis were twice as likely to have a cervi-
cal chlamydial infection than those without. This
finding probably reflects the presence of chlamydia
urethritis in these patients and indicates that clini-
cians should be suspicious of a chlamydial cervi-
cal infection in the setting of a lower urinary-tract
infection as diagnosed by urinalysis in a pregnant
woman.
The ability to clinically diagnose cervical infec-
tions due to N. gonorrhoeae or C. trachomatis may
enable clinicians to reduce the maternal and neona-
tal sequelae of these infections. Our patient popula-
tion, being primarily indigent, relied heavily upon
the emergency room for health care. Therefore,
we have chosen to treat all presumptive cases of
gonococcal or chlamydial cervical infections (cervi-
citis), assuming that we may not be able to relay a
positive test result and offer treatment once the
patient has been discharged from the emergency
department. The present study shows that the clini-
cal diagnosis of mucopurulent cervicitis is a poor
predictor of endocervical infection with N. gonor-
rhoeae or C. trachomatis, with 10/248 (4%) cases posi-
tive for N. gonorrhoeae, and 42/248 (17%) positive
for C. trachomatis, for a total of49/248 (20%) positive
for one or the organism. It appears that we overtreat
a large number of patients (80%), exposing them
to unnecessary antibiotic therapy. The Centers for
Disease Control (CDC) recommends the treatment
of mucopurulent cervicitis based on the results of
testing for C. trachomatis and N. gonorrhoeae, but
cautions that empirical treatment should be given
if the likelihood of infection with either of these
organisms is high or the patient is not likely to
return for treatment.
From the data evaluated, we should have a
higher index of suspicion for an endocervical chla-
mydial infection in pregnancy if the patient is
younger than 24 years or has a urinalysis consistent
with a lower urinary-tract infection in the setting
of clinical cervicitis. There were no identifiable reli-
able predictors for cervical gonococcal infections.
Finally, we should attempt to improve our clinical
prediction of gonococcal or chlamydial cervical in-
fections in pregnantwomen presenting to our emer-
gency department.
As this study evaluated an urban, indigent group
of patients, who are at higher risk of cervical infec-
tions, this information is only applicable to similar
patient populations. By the inclusion criteria for the
study, we preselected a group of patients with an
inherently higher risk for gonococcal and chlamyd-
ial cervical infections. As there were relatively small
numbers of patients with positive test results, a
subgroup analysis of the data introduces the possi-
bility of a type II error. A larger sample size would
help to alleviate this problem and improve the
power of the study. A prospective examination of
pregnant women with and without the diagnosis of
endocervicitis utilizing cultures for C. trachomatis
and N. gonorrhoeae may identify predictors useful
for the clinical identification of a true gonococcal
or chlamydial endocervical infection in pregnancy.
In summary, the clinical indicators of cervical
infection with C. trachomatis and N. gonorrhoeae were
unreliable in our patient population. In light of
these findings, continued screening of this patient
population for these STDs is recommended.
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